Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03252314 · ClinicalTrials.gov registry record
Ruptured Aneurysms Treated With Hydrogel Coils
A clinical trial of Ruptured Aneurysm, sponsored by Microvention-Terumo.
- Active
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03252314: Active study of Ruptured Aneurysm, sponsored by Microvention-Terumo.
NCT03252314 is a study of Ruptured Aneurysm that is active but no longer recruiting, run by Microvention-Terumo. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03252314, a study of Ruptured Aneurysm, is active but no longer recruiting, sponsored by Microvention-Terumo.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.
Conditions Studied
Interventions
- DEVICE Second-generation hydrogel coils
Study Locations (1)
Tennessee
- Methodist University Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03252314
The ClinicalTrials.gov registry entry for NCT03252314 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Microvention-Terumo, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ruptured Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Second-generation hydrogel coils is the first listed.
NCT03252314 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03252314 about?
NCT03252314 is a clinical study titled "Ruptured Aneurysms Treated With Hydrogel Coils". To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.
What is the current status of trial NCT03252314?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2017-11-27. Estimated completion is 2025-12.
What conditions does trial NCT03252314 study?
This clinical trial studies the following conditions: Ruptured Aneurysm.
What interventions are being tested in trial NCT03252314?
The interventions under investigation include: Second-generation hydrogel coils (DEVICE).
Who is sponsoring clinical trial NCT03252314?
This trial is sponsored by Microvention-Terumo, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03252314 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.